These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

419 related items for PubMed ID: 17572715

  • 21. Fractionated TBI correlates with less T cell mixed chimerism but increased risk of relapse compared to busulphan in patients with haematological malignancies after allogeneic stem cell transplantation.
    Mattsson J, Uzunel M, Remberger M, Hassan M.
    Bone Marrow Transplant; 2003 Sep; 32(5):477-83. PubMed ID: 12942093
    [Abstract] [Full Text] [Related]

  • 22. Outcomes of patients with acute leukaemia who relapsed after reduced-intensity stem cell transplantation from HLA-identical or one antigen-mismatched related donors.
    Kobayashi K, Kami M, Murashige N, Kusumi E, Kishi Y, Hamaki T, Hori A, Matsumura T, Yuji K, Masuo S, Mori S, Miyakoshi S, Tanosaki R, Mitamura T, Takaue Y, Taniguchi S, Tokyo SCT Consortium Institution.
    Br J Haematol; 2005 Jun; 129(6):795-802. PubMed ID: 15953007
    [Abstract] [Full Text] [Related]

  • 23. Improved outcome in young adults with de novo acute myeloid leukemia in first remission, undergoing an allogeneic bone marrow transplant.
    Vicente D, Lamparelli T, Gualandi F, Occhini D, Raiola AM, Ibatici A, Van Lint MT, Gobbi M, Miglino M, Clavio M, Risso M, Frassoni F, Bacigalupo A.
    Bone Marrow Transplant; 2007 Aug; 40(4):349-54. PubMed ID: 17589537
    [Abstract] [Full Text] [Related]

  • 24. Allogeneic bone marrow transplant or second autograft in patients with acute leukemia who relapse after an autograft. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
    Ringdén O, Labopin M, Frassoni F, Sanz G, Demeocq F, Prentice H, Cahn JY, Barbui T, Meloni G, Schaefer U, Reiffers J, Gorin N.
    Bone Marrow Transplant; 1999 Aug; 24(4):389-96. PubMed ID: 10467328
    [Abstract] [Full Text] [Related]

  • 25. The outcome of sibling and unrelated donor allogeneic stem cell transplantation in adult patients with acute myeloid leukemia in first remission who were initially refractory to first induction chemotherapy.
    Cook G, Clark RE, Crawley C, Mackinnon S, Russell N, Thomson K, Pearce RM, Towlson K, Marks DI.
    Biol Blood Marrow Transplant; 2006 Mar; 12(3):293-300. PubMed ID: 16503498
    [Abstract] [Full Text] [Related]

  • 26. Intravenous busulfan and melphalan, tacrolimus, and short-course methotrexate followed by unmodified HLA-matched related or unrelated hematopoietic stem cell transplantation for the treatment of advanced hematologic malignancies.
    Small TN, Young JW, Castro-Malaspina H, Prockop S, Wilton A, Heller G, Boulad F, Chiu M, Hsu K, Jakubowski A, Kernan NA, Perales MA, O'Reilly RJ, Papadopoulos EB.
    Biol Blood Marrow Transplant; 2007 Feb; 13(2):235-44. PubMed ID: 17241929
    [Abstract] [Full Text] [Related]

  • 27. Relapse, not regimen-related toxicity, was the major cause of treatment failure in 11 children with Down syndrome undergoing haematopoietic stem cell transplantation for acute leukaemia.
    Meissner B, Borkhardt A, Dilloo D, Fuchs D, Friedrich W, Handgretinger R, Peters C, Schrauder A, Schuster FR, Vormoor J, Maecker B, Sykora KW, Zintl F, Welte K, Sauer M.
    Bone Marrow Transplant; 2007 Nov; 40(10):945-9. PubMed ID: 17768387
    [Abstract] [Full Text] [Related]

  • 28. Single-centre experience with allogeneic bone marrow transplantation for acute lymphoblastic leukaemia in childhood: similar survival after matched-related and matched-unrelated donor transplants.
    Al-Kasim FA, Thornley I, Rolland M, Lau W, Tsang R, Freedman MH, Saunders EF, Calderwood S, Doyle JJ.
    Br J Haematol; 2002 Feb; 116(2):483-90. PubMed ID: 11841456
    [Abstract] [Full Text] [Related]

  • 29. [Allogeneic hematopoietic stem cell transplantation for acute lymphocytic leukemia].
    Chen H, Ren HY, Guo NL, Huang XJ, Liu KY, Xu LP, Zhang YC, Zheng H, Wu T, Liu DH, Yang SM, Lu DP.
    Zhonghua Xue Ye Xue Za Zhi; 2004 Feb; 25(2):87-90. PubMed ID: 14990046
    [Abstract] [Full Text] [Related]

  • 30. G-CSF given after haematopoietic stem cell transplantation using HLA-identical sibling donors is associated to a higher incidence of acute GVHD II-IV.
    Remberger M, Naseh N, Aschan J, Barkholt L, LeBlanc K, Svennberg P, Ringdén O.
    Bone Marrow Transplant; 2003 Jul; 32(2):217-23. PubMed ID: 12838288
    [Abstract] [Full Text] [Related]

  • 31. Hematopoietic stem cell transplantation after reduced intensity conditioning in acute myelogenous leukemia patients older than 40 years.
    Huisman C, Meijer E, Petersen EJ, Lokhorst HM, Verdonck LF.
    Biol Blood Marrow Transplant; 2008 Feb; 14(2):181-6. PubMed ID: 18215778
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Outcomes of adults with acute myelogenous leukemia in remission given 550 cGy of single-exposure total body irradiation, cyclophosphamide, and unrelated donor bone marrow transplants.
    Hallemeier C, Girgis M, Blum W, Brown R, Khoury H, Goodnough LT, Vij R, Devine S, Wehde M, Postma S, Lin HS, Dipersio J, Adkins D.
    Biol Blood Marrow Transplant; 2004 May; 10(5):310-9. PubMed ID: 15111930
    [Abstract] [Full Text] [Related]

  • 36. Risk factors for acute graft-versus-host disease grades II-IV after reduced intensity conditioning allogeneic stem cell transplantation with unrelated donors: a single centre study.
    Remberger M, Mattsson J, Hassan Z, Karlsson N, LeBlanc K, Omazic B, Okas M, Sairafi D, Ringdén O.
    Bone Marrow Transplant; 2008 Feb; 41(4):399-405. PubMed ID: 17982493
    [Abstract] [Full Text] [Related]

  • 37. Total body irradiation with or without lung shielding for allogeneic bone marrow transplantation.
    Labar B, Bogdanić V, Nemet D, Mrsić M, Vrtar M, Grgić-Markulin L, Kalenić S, Vujasinović S, Presecki V, Jakić-Razumović J.
    Bone Marrow Transplant; 1992 May; 9(5):343-7. PubMed ID: 1617318
    [Abstract] [Full Text] [Related]

  • 38. Allogeneic related donor hematopoietic stem cell transplantation for treatment of chronic lymphocytic leukemia.
    Doney KC, Chauncey T, Appelbaum FR, Seattle Bone Marrow Transplant Team.
    Bone Marrow Transplant; 2002 May; 29(10):817-23. PubMed ID: 12058231
    [Abstract] [Full Text] [Related]

  • 39. A dose escalation study of total body irradiation followed by high-dose etoposide and allogeneic blood stem cell transplantation for the treatment of advanced hematologic malignancies.
    Sobecks RM, Daugherty CK, Hallahan DE, Laport GF, Wagner ND, Larson RA.
    Bone Marrow Transplant; 2000 Apr; 25(8):807-13. PubMed ID: 10808200
    [Abstract] [Full Text] [Related]

  • 40. Reduced-intensity stem-cell transplantation for adult acute lymphoblastic leukemia: a retrospective study of 33 patients.
    Hamaki T, Kami M, Kanda Y, Yuji K, Inamoto Y, Kishi Y, Nakai K, Nakayama I, Murashige N, Abe Y, Ueda Y, Hino M, Inoue T, Ago H, Hidaka M, Hayashi T, Yamane T, Uoshima N, Miyakoshi S, Taniguchi S.
    Bone Marrow Transplant; 2005 Mar; 35(6):549-56. PubMed ID: 15756282
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.